- Home
- DUOT vs PALI Comparison
DUOT vs PALI Comparison
Compare DUOT & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DUOT | PALI |
|---|---|---|
| Founded | 1990 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 261.2M | 359.0M |
| IPO Year | 2017 | 2019 |
Fundamental Metrics
Financial Performance| Metric | DUOT | PALI |
|---|---|---|
| Price | $8.61 | $1.63 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | ★ $17.00 | $11.29 |
| AVG Volume (30 Days) | 733.7K | ★ 2.1M |
| Earning Date | 05-14-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 53.96 | ★ 97.06 |
| EPS | ★ 1.37 | N/A |
| Revenue | ★ $27,023,651.00 | $260,000.00 |
| Revenue This Year | $50.98 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $6.20 | ★ N/A |
| Revenue Growth | 271.16 | ★ 1500.39 |
| 52 Week Low | $6.17 | $0.58 |
| 52 Week High | $15.28 | $2.86 |
Technical Indicators
Market Signals| Indicator | DUOT | PALI |
|---|---|---|
| Relative Strength Index (RSI) | 43.55 | 32.43 |
| Support Level | $8.04 | $1.57 |
| Resistance Level | $8.61 | $2.20 |
| Average True Range (ATR) | 0.38 | 0.12 |
| MACD | -0.06 | -0.05 |
| Stochastic Oscillator | 32.62 | 5.51 |
Price Performance
Historical ComparisonAbout DUOT Duos Technologies Group Inc.
Duos Technologies Group Inc delivers AI-driven technologies, edge computing infrastructure, and energy consulting services to support data-intensive and mission-critical operations. It manages, operates, engineers, software development, customer support and project implementation and management across three market segments, including rail technology deployment, Data Center co-location facilities, and behind-the-meter electrical power provision. It also continues to operate as a technology company which designs, develops, deploys, and operates intelligent technology solutions with a focus on software applications and artificial intelligence (AI) in addition to large projects, consulting, implementation, and asset management.
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.